Jeffrey Stark, MD, vice president, head of medical immunology, UCB, discusses ongoing clinical trials and the development of ...

Panelists discuss how the introduction of Janus kinase (JAK) inhibitor therapies will likely change treatment algorithms for alopecia areata (AA), with insights on how payers should plan for coverage ...

The Republican bill for the congressional budget narrowly passes the House of Representatives, advancing to the Senate floor.

Delays in receiving coverage for essential medications like insulin and albuterol can worsen symptoms, increase costs, and ...

Long COVID is the chronic manifestation of lasting symptoms of SARS-CoV-2 infection that can last for at least 3 months, with shortness of breath and system inefficiency often remaining central issues ...

Medicare Advantage (MA) plans, with fixed payments based on medical complexity, incentivize aggressive coding of comorbidities, potentially inflating costs for the federal government, according to ...

Attendees can expect insights on advancements in glaucoma care, myopia management, dry eye treatments, emerging technologies, ...

Building trust with patients who are dually eligible for Medicaid and Medicare can help to improve their lives as they navigate receiving care to address their clinical and behavioral health needs.

Adolescents who are treatment-naive had promising results when using dolutegravir/lamivudine as antiretroviral therapy over ...

Of the surveyed physicians, 93% reported that prior authorization delays patient care, and 89% said it contributes to burnout ...

These findings support the claim that Medicare Advantage (MA) payments may be driven more by diagnosis and coding practices ...

Jeffrey Stark, MD, vice president and head of medical immunology at UCB, analyzes the Bimzelx Navigate program, a ...